This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2004-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2006
Title: Goos Van Muijen: Innovator in Cancer Research
Introduction
Goos Van Muijen is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of cancer research, particularly in the development of processes that assess tumor potential in human cells. With a total of 2 patents, his work is pivotal in advancing medical diagnostics.
Latest Patents
Van Muijen's latest patents include a process for determining the tumoricidal potential of a sample using a nucleic acid that is downregulated in human tumor cells. This innovative process analyzes whether a cancer cell-containing test sample has potential for tumor development, progression, or metastasis. It involves comparing hybridization amounts between the test sample and a second sample from non-tumor cells. His second patent focuses on the determination of CTp11 and assessing whether a tumor sample has metastatic potential.
Career Highlights
Goos Van Muijen is associated with Hoffmann-La Roche Inc., where he continues to contribute to groundbreaking research in oncology. His expertise in molecular biology and cancer diagnostics has positioned him as a key figure in his field.
Collaborations
He has collaborated with notable colleagues such as Tobias Hildebrandt and Ulrich Weidle, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Goos Van Muijen's innovative work in cancer research exemplifies the importance of scientific advancements in medical diagnostics. His patents reflect a commitment to improving cancer detection and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile